The government Cabinet has given the green light for an extension to the Marmoset vaccine testing project, a crucial initiative focused on evaluating the safety and effectiveness of a subunit vaccine candidate for the prevention of COVID-19. Deputy Government Spokesperson Traisulee Traisoranakul disclosed that the project’s original termination date was slated for last month. However, due to various challenges encountered during its implementation, the timeline has been extended until December 29 of this year.
One of the key hurdles that prompted the extension was the difficulty in procuring and delivering marmosets, which play a vital role in the testing process. These delays necessitated an elongated project timeline to accommodate the completion of the necessary procedures and evaluations.
Furthermore, the Cabinet has also granted an extension for Phase 2A human trials of a plant-based subunit vaccine candidate until December 29, 2023. Several factors influenced this decision, including the consideration of safety data gathered from previous trials. The extended timeline aims to ensure that comprehensive assessments are conducted to maximize both the safety and efficacy of the vaccine candidate.
In addition to these significant developments, the Cabinet has authorized adjustments to a total of 99 projects spanning multiple provinces, with a combined budget of 422.55 million baht. These modifications encompass the cancellation, timeline extension, or alteration of crucial project details. The objective behind these adjustments is to optimize the execution and outcomes of these projects, ensuring their alignment with current priorities and objectives.
As the government continues its commitment to combating the COVID-19 pandemic and advancing research and development efforts, these approvals and adjustments demonstrate a proactive approach in addressing challenges and promoting the effective implementation of critical initiatives.
The government Cabinet has given the green light for an extension to the Marmoset vaccine testing project, a crucial initiative focused on evaluating the safety and effectiveness of a subunit vaccine candidate for the prevention of COVID-19. Deputy Government Spokesperson Traisulee Traisoranakul disclosed that the project’s original termination date was slated for last month. However, due to various challenges encountered during its implementation, the timeline has been extended until December 29 of this year.
One of the key hurdles that prompted the extension was the difficulty in procuring and delivering marmosets, which play a vital role in the testing process. These delays necessitated an elongated project timeline to accommodate the completion of the necessary procedures and evaluations.
Furthermore, the Cabinet has also granted an extension for Phase 2A human trials of a plant-based subunit vaccine candidate until December 29, 2023. Several factors influenced this decision, including the consideration of safety data gathered from previous trials. The extended timeline aims to ensure that comprehensive assessments are conducted to maximize both the safety and efficacy of the vaccine candidate.
In addition to these significant developments, the Cabinet has authorized adjustments to a total of 99 projects spanning multiple provinces, with a combined budget of 422.55 million baht. These modifications encompass the cancellation, timeline extension, or alteration of crucial project details. The objective behind these adjustments is to optimize the execution and outcomes of these projects, ensuring their alignment with current priorities and objectives.
As the government continues its commitment to combating the COVID-19 pandemic and advancing research and development efforts, these approvals and adjustments demonstrate a proactive approach in addressing challenges and promoting the effective implementation of critical initiatives.
